Canadian dyslipidemia guidelines application
advertisement
| Naam | CardioRisk |
|---|---|
| Versie | 1.6.9 |
| Update | 07 okt. 2023 |
| Grootte | 3 MB |
| Categorie | Medisch |
| Installaties | 10K+ |
| Ontwikkelaar | The University of British Columbia |
| Android OS | Android 4.0.3+ |
| Google Play ID | ca.ubc.circl.cardiorisk |
CardioRisk · Schermafbeeldingen
CardioRisk · Beschrijving
CardioRisk Calculator™ simplifies cardiovascular risk stratification and is a Canadian dyslipidemia guidelines application.
CardioRisk Calculator™ provides:
-quick calculations on % LDL-C reductions
-concise drug dosage information
-clear snapshot of a patient's CV risk
-options to bring lipid levels to target
-easy identification of familial hypercholesterolemia
This application has been developed with the ultimate goal of educating physicians on the most recent Canadian dyslipidemia guidelines and guidelines for the diagnosis of familial hypercholesterolemia.
Programming support for the CardioRisk Calculator™ was provided through unrestricted grants to support the CardioRisk Clinic from the following (in alphabetical order):
Amgen Canada
Bayer Inc
Boehringer Ingelheim (Canada) Ltd
FH Canada
HLS Therapeutics
Janssen Inc
Novo Nordisk Canada
Sanofi Canada
CardioRisk Calculator™ provides:
-quick calculations on % LDL-C reductions
-concise drug dosage information
-clear snapshot of a patient's CV risk
-options to bring lipid levels to target
-easy identification of familial hypercholesterolemia
This application has been developed with the ultimate goal of educating physicians on the most recent Canadian dyslipidemia guidelines and guidelines for the diagnosis of familial hypercholesterolemia.
Programming support for the CardioRisk Calculator™ was provided through unrestricted grants to support the CardioRisk Clinic from the following (in alphabetical order):
Amgen Canada
Bayer Inc
Boehringer Ingelheim (Canada) Ltd
FH Canada
HLS Therapeutics
Janssen Inc
Novo Nordisk Canada
Sanofi Canada
